RETROSPECTIVE OBSERVATIONAL STUDY OF CHEMOTHERAPY IN ELDERLY PATIENTS IN THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
In this retrospective observational study, the case series of patients undergoing first-line treatment for metastatic colorectal adenocarcinoma with doublet fixed-dose and reduced-dose chemotherapy in combination with full-dose monoclonal antibody in patients aged 70 years or older is collected.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 70
Maximum Age: 99
Healthy Volunteers: f
View:
• Patients with metastatic colorectal adenocarcinoma not treated with any therapy in the metastatic phase. Previous (neo)-adjuvant treatment with fluoroderivatives with or without Oxaliplatin is permitted.
• Age ≥ 70 years
• G8 score ≥ 12
• Patients with colorectal adenocarcinoma MSS
• Patients with BRAF WT colorectal adenocarcinoma
• Ability to understand and sign the informed consent form.
Locations
Other Locations
Italy
E.O. Ospedali Galliera
NOT_YET_RECRUITING
Genoa
E.O. Ospedali Galliera
RECRUITING
Genova
Contact Information
Primary
Matteo Clavarezza
matteo.clavarezza@galliera.it
010.5634580
Backup
Davide S Corradengo
davide.corradengo@galliera.it
010.5634580
Time Frame
Start Date: 2026-07-07
Estimated Completion Date: 2027-07-31
Participants
Target number of participants: 51
Treatments
Retrospective
PATIENTS AGED 70 YEARS AND OVER IN FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
Related Therapeutic Areas
Sponsors
Leads: Matteo Clavarezza